MindMed to Participate in Upcoming Investor Conferences
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:Jefferies London Healthcare ConferenceFormat: 1x1 MeetingsDates: November 20-21, 2024Location: London, UK7th Annual Evercore HealthCONx ConferenceFormat: Fireside Chat and 1x1 MeetingsDate and Time: Thursday, December 5, 2024 at 11:15 PM ETLocation: Coral Gables, FLWebcast Link: 7th Annual Evercore HealthCONx ConferenceAudio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following each event.About MindMedMindMed is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the developmen
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.MarketBeat
- MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety DisorderBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock.MarketBeat
- Why Mind Medicine Stock Is Soaring Today [Yahoo! Finance]Yahoo! Finance
MNMD
Earnings
- 11/7/24 - Beat
MNMD
Sec Filings
- 2/5/25 - Form SCHEDULE
- 1/30/25 - Form 8-K
- 1/13/25 - Form 8-K
- MNMD's page on the SEC website